Claude Allasia

2.3k citations
58 papers · 1.9k indexed · h-index 26

Claude Allasia

58 papers receiving 1.8k citations

Peers

Claude Allasia
Comparison fields: 5 of 99
  • Molecular Biology 875
  • Oncology 718
  • Cancer Research 527
  • Immunology and Allergy 252
  • Public Health, Environmental and Occupational Health 244
Replace Keiko Okuda with:
Keiko Okuda Japan
Leia M. Smith United States
Yvon E. Cayre France
Brent L. Kreider United States
J. P. Johnson Germany
Andréas Tsapis France
Eliana Bignotti Italy
John F. Lyons United States
Francesca Luciani Italy
John R. MacDougall United States
Claude Allasia relative to Keiko Okuda Japan Keiko Okuda's profile →
Citations per field
00.5×2.9×
Keiko Okuda · 1×
Citations per year

Countries citing papers authored by Claude Allasia

Since Specialization
Citations

This map shows the geographic impact of Claude Allasia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claude Allasia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claude Allasia more than expected).

Fields of papers citing papers by Claude Allasia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claude Allasia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claude Allasia. The network helps show where Claude Allasia may publish in the future.

Co-authorship network of co-authors of Claude Allasia

This figure shows the co-authorship network connecting the top 25 collaborators of Claude Allasia. A scholar is included among the top collaborators of Claude Allasia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claude Allasia. Claude Allasia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 47
2 2
3 207
4 51
5 46
6 46
7 34
8 10
9 30
10 12
11 70
12 20
13 7
14 19
15
Inflammatory breast carcinoma: an immunohistochemical study using monoclonal anti-pHER-2/neu, pS2, cathepsin, ER and PR.
37
16 24
17 87
18 2
19 2
20 33

About Claude Allasia

Claude Allasia is a scholar working on Immunology and Allergy, Oncology and Cancer Research, having authored 58 papers that have together received 1.9k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (13 papers), HER2/EGFR in Cancer Research (12 papers) and Cell Adhesion Molecules Research (12 papers). The work is most often cited by research in Immunology and Allergy (252 citations), Cancer Research (527 citations) and Oncology (718 citations). Claude Allasia has collaborated with scholars based in France, United States and Austria. Frequent co-authors include Colette Charpin, Pascal Bonnier, L Andrac, Stéphane Garcia, Jean-Philippe Dalès, Marie‐Noëlle Lavaut, Lucile Andrac‐Meyer, M N Lavaut, C. Cataldo and Charles Mackenzie. Their work appears in journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026